Anesthesia for Patients with Myasthenia Gravis
Neuromuscular (NM) diseases are a common cause of morbidity and mortality. Myasthenia gravis (MG) is characterized by skeletal muscle weakness and fatigability. In essence, MG is an autoimmune disease that results from the destruction of post-synaptic nicotinic acetylcholine (ACh)
Isolated dysarthria as the sole manifestation of myasthenia gravis: A Case Report
Myasthenia gravis (MG) is a disorder of neuromuscular transmission, resulting from binding of autoantibodies to components of
Inflammation and autoimmune myasthenia gravis
Myasthenia gravis (MG) is a neuromuscular autoimmune disorder characterized by chronic but intermittent fatigue of the eye- and general body muscles. Muscle weakness is caused primarily by the binding of an autoantibody to the acetylcholine receptors, resulting in blockage of normal neuromuscular signal transmission. Inflammation has long been regarded as an important contributing factor for […]